Related Experiment Video
Updated: Apr 20, 2026
05:33
Author Spotlight: Characterizing Novel Enzymes from Extremophiles and Common Pathogens to Understand DNA Repair and Replication
Published on: July 5, 2024
1.6K
High-throughput chemical modification of oligonucleotides for systematic structure-activity relationship evaluation
Daniel Zewge1, Francis Gosselin, Denise M Kenski
1Department of Process Chemistry, Merck Research Laboratories , Rahway, New Jersey 07065, United States.
Bioconjugate Chemistry
|November 15, 2014
Summary
Copper catalyzed azide-alkyne cycloadditions enable high-throughput chemical modification of small interfering RNA (siRNA). This method allows rapid, specific, and efficient synthesis for systematic biological evaluation of modified siRNA.
Area of Science:
- Medicinal Chemistry
- Molecular Biology
- Biotechnology
Background:
- Chemical modification of small interfering RNA (siRNA) is crucial for enhancing its stability, delivery, and therapeutic efficacy.
- Current methods for siRNA modification can be complex, time-consuming, and lack scalability for comprehensive biological evaluation.
Purpose of the Study:
- To develop a high-throughput method for chemical modification of siRNA using copper-catalyzed azide-alkyne cycloadditions (CuAAC).
- To demonstrate the efficiency, specificity, and applicability of CuAAC for creating diverse modified siRNA molecules for rapid biological screening.
Main Methods:
- Utilized copper-catalyzed azide-alkyne cycloadditions (CuAAC) in a 96-well plate format for efficient siRNA modification.
- Performed modifications in a single synthetic step at up to four distinct positions on the siRNA molecule.
Main Results:
- Achieved complete specificity and good yields with acceptable purity for the synthesized modified siRNA.
- Demonstrated the ability to modify up to four positions on siRNA in one synthetic operation.
Conclusions:
- The CuAAC approach provides a versatile and scalable platform for the chemical modification of siRNA.
- This method significantly expands synthetic options for oligonucleotide modifications, enabling rapid biological assessment of modified siRNA candidates.
